We are an international network of healthcare professionals, researchers and consumers preparing, maintaining, and disseminating systematic reviews of randomised control trials for treating cystic fibrosis and other genetic disorders (haemoglobinopathies. coagulopathies and inborn errors of metabolism). Our editorial base is located within the Department of Women's and Children's Health, University of Liverpool and based at the Institute in the Park which is part of Alder Hey Children's NHS Foundation Trust, Liverpool, United Kingdom.
|We have published an update of our review of hydroxyurea (hydroxycarbamide) for sickle cell disease. The latest version includes six new studies, bringing the total number of included studies to eight (almost 900 participants) lasting up to 30 months.|
Latest output published on The Cochrane Library
On Issue 4, 2017 of The Cochrane Library we have published a total of 163 reviews and 28 protocols. There are also 20 registered titles currently progressing to protocol status. The production of these reviews involves a network of over 1000 contributors (authors, consumers and referees) throughout the world. We very much welcome interest from new consumers, referees and potential reviewers. Further information can be obtained by contacting the group.